申请人:UCB PHARMA GMBH
公开号:US11345662B2
公开(公告)日:2022-05-31
Disclosed are sulfonamide compounds with GPR17 modulating properties, which are useful for treating or preventing a variety of CNS and other diseases, in particular for preventing and treating myelinating diseases or disorders.
所公开的磺酰胺化合物具有调节 GPR17 的特性,可用于治疗或预防各种中枢神经系统疾病和其他疾病,特别是预防和治疗髓鞘疾病或紊乱。